TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
3D Medicines, Inc. ( (HK:1244) ) has provided an announcement.
3D Medicines Inc. has announced its upcoming annual general meeting scheduled for June 30, 2025, in Beijing, where shareholders will consider various resolutions, including the adoption of the 2024 financial statements and the election and re-election of directors. The meeting will also address the re-appointment of the company’s auditor and authorize the board to manage director remuneration and share allotments, indicating a focus on strengthening governance and operational oversight.
More about 3D Medicines, Inc.
3D Medicines Inc. operates in the biotechnology industry, focusing on the development and commercialization of innovative cancer therapies. The company is committed to advancing precision medicine through its research and development efforts, targeting significant unmet medical needs in oncology.
Average Trading Volume: 277,741
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.09B
See more insights into 1244 stock on TipRanks’ Stock Analysis page.